Biểu đồ giá cổ phiếu SRRK
SRRK Tài chính
Scholar Rock Holding Corp
$52.92
0.53%
$0.28
Khi đóng cửa: Aug 07, 16:00:00 GMT-4
$53.89
1.83%
$0.96
Phiên sau giờ: Aug 07, 18:39:09 GMT-4
Quay lại
Scholar Rock Holding Corp (SRRK) Tài chính
Thống kê chính
Giá đóng cửa trước
$52.64
Giá mở cửa
$53.3
Phạm vi ngày
$50.76 - $53.89
Phạm vi 52 tuần
$27.07 - $58.49
Khối lượng
--
Khối lượng trung bình
1.4M
Tỷ suất cổ tức
--
EPS (TTM)
-3.45
Vốn hóa thị trường
$6.4B
SRRK là gì?
Scholar Rock Holding Corp. is a biopharmaceutical company. The company is headquartered in Cambridge, Massachusetts and currently employs 289 full-time employees. The company went IPO on 2018-05-24. The firm focuses on improving the lives of children and adults with spinal muscular atrophy (SMA) and additional rare, severe and debilitating neuromuscular diseases. Its pipeline product candidates include apitegromab, a subcutaneous formulation of apitegromab, and SRK-439. The Apitegromab is an investigational fully human, intravenously administered monoclonal antibody designed to inhibit myostatin activation by selectively binding the pro- and latent forms of myostatin in the skeletal muscle. The SRK-439, is an investigational, subcutaneously administered fully human anti-pro/latent myostatin antibody that has high inhibitory potency while maintaining selectivity towards myostatin. Its early-stage pipeline includes additional programs for the treatment of patients with rare, severe, and debilitating neuromuscular diseases.
